CD8+ lymphomatoid papulosis and its differential diagnosis

American Journal of Clinical Pathology

Volumn 125, Issue 4, 2006, Pages 490-501

  Magro, Cynthia M ^a   Crowson, A Neil ^b   Morrison, Carl ^a   Merati, Kambiz ^a   Porcu, Pierluigi ^a   Wright, E David ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c Southwest Skin Pathology Services   (United States)

Author keywords

Aggressive CD8 lymphoma; CD8; Lymphomatoid papulosis

Indexed keywords

ALPHA INTERFERON; BLEOMYCIN; CD30 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; PSORALEN; VINCRISTINE SULFATE;

ADOLESCENT; ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CELL MEMBRANE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; GOLGI COMPLEX; GRANULOMATOUS INFLAMMATION; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LYMPHOMATOID PAPULOSIS; LYMPHOPROLIFERATIVE DISEASE; MALE; MICROSCOPY; PHENOTYPE; PRIORITY JOURNAL; PUVA; T CELL LYMPHOMA; TESTIS DISEASE;

EID: 33645543941     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/NNV4L5G5A0KF1T06     Document Type: Article

References (33)

1. Orchard GE. Lymphomatoid papulosis: a low-grade T-cell lymphoma? Br J Biomed Sci. 1996;53:162-169.
2. LeBoit PE. Lymphomatoid papulosis and cutaneous CD30+ lymphoma. Am J Dermatopathol. 1996;18:221-235.
3. Louvet S, Dompmartin A, Troussard X, et al. Spectrum of CD30 lymphoproliferative diseases from lymphomatoid papulosis to anaplastic large cell lymphoma. Int J Dermatol. 1996;35:842-848.
4. Drews R, Samel A, Kadin ME. Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin. Semin Cutan Med Surg. 2000;19:109-117.
5. Karp DL, Horn TD. Lymphomatoid papulosis. J Am Acad Dermatol. 1994;30:379-395.
6. Sanchez NP, Pittelkow MR, Muller SA, et al. The clinicopathologic spectrum of lymphomatoid papulosis: study of 31 cases. J Am Acad Dermatol. 1983;8:81-94.
7. Davis TH, Morton CC, Miller-Cassman R, et al. Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med. 1992;326:1115-1122.
8. Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders: a proposal for classification and guidelines for management and treatment. J Am Acad Dermatol. 1993;28:973-980.
9. Tan SH, Sim CS, Ong BH. Cutaneous lymphomas other than mycosis fungoides in Singapore: a clinicopathological analysis using recent classification systems. Br J Dermatol. 2003;149-.542-553.
10. Boulland ML, Wechsler J, Bagot M, et al. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins. Histopathology. 2000;36:136-144.
11. Kummer JA, Vermeer MH, Dukers D, et al. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype. J Invest Dermatol. 1997;109:636-640.
12. Kadin ME. Characteristic immunologic profile of large atypical cells in lymphomatoid papulosis: possible implications for histogenesis and relationship to other diseases [editorial]. Arch Dermatol. 1986;122:1388-1390.
13. Hellman J, Phelps RG, Baral J, et al. Lymphomatoid papulosis with antigen deletion and clonal rearrangement in a 4-year-old boy. Pediatr Dermatol. 1990;7:42-47.
14. Wu WM, Tsai HJ. Lymphomatoid papulosis histopathologically simulating angiocentric and cytotoxic T-cell lymphoma: a case report. Am J Dermatopathol. 2004;26:133-135.
15. Berti E, Tomasini D, Vermeer MH, et al. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas: a distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol. 1999;155:483-492.
16. Aoki E, Aoki M, Kono M, et al. Two cases of lymphomatoid papulosis in children. Pediatr Dermatol. 2003;20:146-149.
17. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317.
18. Droese J, Langerak AW, Groenen PJ, et al. Validation of BIOMED-2 multiplex PCR tubes for detection of TCRB gene rearrangements in T-cell malignancies. Leukemia. 2004;18:1531-1538.
19. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood. 1997;90:354-371.
20. Willemze R, Meijer CJ, for the European Organization for Research and Treatment of Cancer. EORTC classification for primary cutaneous lymphomas: the best guide to good clinical management. Am J Dermatopathol. 1999;21:265-273.
21. Tao J, Shelat SG, Jaffe ES, et al. Aggressive Epstein-Barr virus-associated, CD8+, CD30+, CD56+, surface CD3-, natural killer (NK)-like cytotoxic T-cell lymphoma. Am J Surg Pathol. 2002;26:111-118.
22. Urrutia S, Piris MA, Orradre JL, et al. Cytotoxic/suppressor (CD8+, CD4-) cutaneous T-cell lymphoma with aggressive course. Am J Dermatopathol. 1990;12:603-606.
23. Willemze R, Jaffe ES, Burg B, et al. WHO-EORTC classification for cutaneous lymphoma. Blood. 2005;105:3768-3785.
24. Crowson AN, Baschinsky D, Kovatich A, et al. Granulomatous eccrinotropic lymphomatoid papulosis. Am J Clin Pathol. 2003;119:731-739.
25. Delfs MW, Furukawa Y, Mitchell RN, et al. CD8+ T cell subsets TC1 and TC2 cause different histopathologic forms of murine cardiac allograft rejection. Transplantation. 2001;71:606-610.
26. Schnickel GT, Whiting D, Hsieh GR, et al. CD8 lymphocytes are sufficient for the development of chronic rejection. Transplantation. 2004;78:1634-1639.
27. Raisky O, Spriewald BM, Morrison KJ, et al. CD8(+) T cells induce graft vascular occlusion in a CD40 knockout donor/recipient combination. J Heart Lung Transplant. 2003;22:177-183.
28. Fischbein MP, Yun J, Laks H, et al. Role of CD8+ lymphocytes in chronic rejection of transplanted hearts. J Thorac Cardiovasc Surg. 2002;123:803-809.
29. Fischbein MP, Yun J, Laks H, et al. CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model. Transplantation. 2001;71:1146-1153.
30. Kreisel D, Krupnick AS, Gelman AE, et al. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat Med. 2002;8:233-239.
31. Kikuchi A, Sakuraoka K, Kurihara S, et al. CD8+ cutaneous anaplastic large-cell lymphoma: report of two cases with immunophenotyping, T-cell-receptor gene rearrangement and electron microscopic studies. Br J Dermatol. 1992;126:404-408.
32. Fukunaga M, Masaki T, Ichihashi M, et al. CD8-positive primary cutaneous anaplastic large cell lymphoma with a fair prognosis. Acta Derm Venereol. 2002;82:312-314.
33. Gelfand JM, Wasik MA, Vittorio C, et al. Progressive epidermotropic CD8+/CD4- primary cutaneous CD30+ lymphoproliferative disorder in a patient with sarcoidosis. J Am Acad Dermatol. 2004;51:304-308.